tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
iBio Announces $50 Million Public Offering Agreement
PremiumCompany AnnouncementsiBio Announces $50 Million Public Offering Agreement
1M ago
iBio 71.54M share Spot Secondary priced at $0.70
Premium
The Fly
iBio 71.54M share Spot Secondary priced at $0.70
1M ago
iBio Highlights Advancements in Obesity Pipeline
Premium
Company Announcements
iBio Highlights Advancements in Obesity Pipeline
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
iBio Advances Obesity Care with Antibody Therapies
Premium
Company Announcements
iBio Advances Obesity Care with Antibody Therapies
3M ago
iBio, AstralBio unveil obesity program with amylin receptor agonist antibody
Premium
The Fly
iBio, AstralBio unveil obesity program with amylin receptor agonist antibody
3M ago
iBio, Inc. Reports Strong Q3 2025 Progress
PremiumCompany AnnouncementsiBio, Inc. Reports Strong Q3 2025 Progress
5M ago
iBio reports Q3 EPS 49c vs 71c last year
Premium
The Fly
iBio reports Q3 EPS 49c vs 71c last year
5M ago
iBio Enters Licensing Agreement for Obesity Treatment
Premium
Company Announcements
iBio Enters Licensing Agreement for Obesity Treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100